Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop

Resistance to chemotherapy, a major therapeutic challenge in the treatment of T-cell acute lymphoblastic leukemia (T-ALL), can be driven by interactions between leukemic cells and the microenvironment that promote survival of leukemic cells. The bone marrow, an important leukemia niche, has low oxyg...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Main Authors: Fahy, Lucine, Calvo, Julien, Chabi, Sara, Renou, Laurent, Le Maout, Charly, Poglio, Sandrine, Leblanc, Thierry, Petit, Arnaud, Baruchel, André, Ballerini, Paola, Naguibneva, Irina, Haddad, Rima, Arcangeli, Marie-Laure, Mazurier, Frederic, Pflumio, Francoise, Uzan, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2021
Assuntos:
Lymphoid Neoplasia
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839374/
https://ncbi.nlm.nih.gov/pubmed/33496749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002832
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares